480 related articles for article (PubMed ID: 34876936)
1. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
Zhan X; Li J; Guo Y; Golubnitschaja O
EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
[TBL] [Abstract][Full Text] [Related]
2. Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients.
Brunmair J; Bileck A; Schmidl D; Hagn G; Meier-Menches SM; Hommer N; Schlatter A; Gerner C; Garhöfer G
EPMA J; 2022 Mar; 13(1):107-123. PubMed ID: 35265228
[TBL] [Abstract][Full Text] [Related]
3. Short communication: unique metabolic signature of proliferative retinopathy in the tear fluid of diabetic patients with comorbidities - preliminary data for PPPM validation.
Kropp M; De Clerck E; Vo TKS; Thumann G; Costigliola V; Golubnitschaja O
EPMA J; 2023 Mar; 14(1):43-51. PubMed ID: 36845280
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions.
Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O
EPMA J; 2020 Sep; 11(3):399-418. PubMed ID: 32843909
[TBL] [Abstract][Full Text] [Related]
5. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
[TBL] [Abstract][Full Text] [Related]
6. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
[TBL] [Abstract][Full Text] [Related]
7. Caution, "normal" BMI: health risks associated with potentially masked individual underweight-EPMA Position Paper 2021.
Golubnitschaja O; Liskova A; Koklesova L; Samec M; Biringer K; Büsselberg D; Podbielska H; Kunin AA; Evsevyeva ME; Shapira N; Paul F; Erb C; Dietrich DE; Felbel D; Karabatsiakis A; Bubnov R; Polivka J; Polivka J; Birkenbihl C; Fröhlich H; Hofmann-Apitius M; Kubatka P
EPMA J; 2021 Sep; 12(3):243-264. PubMed ID: 34422142
[TBL] [Abstract][Full Text] [Related]
8. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.
Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O;
EPMA J; 2021 Dec; 12(4):403-433. PubMed ID: 34539937
[TBL] [Abstract][Full Text] [Related]
9. Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
Hagan S; Martin E; Enríquez-de-Salamanca A
EPMA J; 2016; 7(1):15. PubMed ID: 27413414
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of ocular allergy and dry eye disease.
Zemba M; Ionescu MA; Pîrvulescu RA; Dumitrescu OM; Daniel-Constantin B; Radu M; Stamate AC; Istrate S
Rom J Ophthalmol; 2023; 67(3):250-259. PubMed ID: 37876509
[TBL] [Abstract][Full Text] [Related]
11. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
[TBL] [Abstract][Full Text] [Related]
12. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
[TBL] [Abstract][Full Text] [Related]
13. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation.
Kropp M; Golubnitschaja O; Mazurakova A; Koklesova L; Sargheini N; Vo TKS; de Clerck E; Polivka J; Potuznik P; Polivka J; Stetkarova I; Kubatka P; Thumann G
EPMA J; 2023 Mar; 14(1):21-42. PubMed ID: 36866156
[TBL] [Abstract][Full Text] [Related]
14. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O
EPMA J; 2021 Mar; 12(1):1-14. PubMed ID: 33680218
[TBL] [Abstract][Full Text] [Related]
15. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach.
Tachalov VV; Orekhova LY; Kudryavtseva TV; Loboda ES; Pachkoriia MG; Berezkina IV; Golubnitschaja O
EPMA J; 2021 Jun; 12(2):129-140. PubMed ID: 33897916
[TBL] [Abstract][Full Text] [Related]
16. Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review).
Ma JYW; Sze YH; Bian JF; Lam TC
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760148
[TBL] [Abstract][Full Text] [Related]
17. Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position.
Smokovski I; Steinle N; Behnke A; Bhaskar SMM; Grech G; Richter K; Niklewski G; Birkenbihl C; Parini P; Andrews RJ; Bauchner H; Golubnitschaja O
EPMA J; 2024 Jun; 15(2):149-162. PubMed ID: 38841615
[TBL] [Abstract][Full Text] [Related]
18. Tear biomarkers.
Ponzini E
Adv Clin Chem; 2024; 120():69-115. PubMed ID: 38762243
[TBL] [Abstract][Full Text] [Related]
19. New insight of metabolomics in ocular diseases in the context of 3P medicine.
Zhang Q; Wang N; Rui Y; Xia Y; Xiong S; Xia X
EPMA J; 2023 Mar; 14(1):53-71. PubMed ID: 36866159
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
